Article
A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome.
Journal of molecular medicine (Berlin, Germany) - 1 Oct 2023
Yan Jinhua, Wu Jinzheng, Wang Yang, Di Xiaotang, Jiang Hao, Wen Doudou, Li Duo, Zhang Shubing
Abstract excerpt
Screening tumor susceptibility genes helps in identifying powerful biomarkers for hereditary cancer monitoring, prevention, and diagnosis, providing opportunities for understanding potential molecular mechanisms and biomarkers for the precise treatment of hereditary cancer syndromes. Whole-exome sequencing of blood and bioinformatics analysis uncovered a novel RBBP8(p.E281*) germline mutation in a family with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
